David Boyer Net Worth & Insider Trades
David Boyer - Chief Corp. Affairs Officer, Neurocrine Biosciences Inc
What is David Boyer's Net Worth?
The current estimated net worth of Neurocrine Biosciences Inc's Chief Corp. Affairs Officer, David Boyer, is estimated to be about $3.36M . David Boyer owns about 4,755 units of Neurocrine Biosciences Inc common stock. In the last year at Neurocrine Biosciences Inc, David Boyer has sold an estimated value of $3.08M worth.
What is David Boyer's Past Insider Trading?
David Boyer's largest sale order was 25,238 units , worth over $2.59M on February 8, 2023. In total, David Boyer has made about 6 transactions over a year of their time at Neurocrine Biosciences Inc. David Boyer usually trades in February, with the busiest year in 2023 and 2022.
David Boyer
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David Boyer's' Mailing Address?
- Mailing address is C/o Neurocrine Biosciences, Inc. 12780 el Camino Real San Diego CA 92130 CA
Neurocrine Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Kevin C. Gorman, Ph.D. | 2018 | $675,000 | $425,250 | $4,486,852 | $2,998,832 | $47,045 | $8,632,979 |
| Kevin C. Gorman, Ph.D. | 2019 | $725,000 | $667,000 | $6,000,525 | $2,000,071 | $58,230 | $9,450,826 |
| Kevin C. Gorman, Ph.D. | 2020 | $775,000 | $542,500 | $7,124,633 | $5,375,188 | $63,311 | $13,880,632 |
| Matthew C. Abernethy | 2018 | $420,000 | $199,500 | - | $1,996,506 | $69,741 | $2,685,747 |
| Matthew C. Abernethy | 2019 | $495,600 | $284,970 | $3,750,345 | $1,250,035 | $42,170 | $5,823,120 |
| Matthew C. Abernethy | 2020 | $545,200 | $190,820 | $2,999,869 | $2,500,266 | $45,021 | $6,281,176 |
| Eric Benevich | 2018 | $432,600 | $205,485 | $1,496,335 | $1,499,417 | $38,768 | $3,672,605 |
| Eric Benevich | 2019 | $467,200 | $280,320 | $3,750,345 | $1,250,035 | $45,547 | $5,793,447 |
| Eric Benevich | 2020 | $499,900 | $199,960 | $2,999,869 | $3,000,257 | $48,974 | $6,748,960 |
| Kyle W. Gano, Ph.D. | 2018 | $403,100 | $191,473 | $1,309,024 | $2,656,575 | $8,069 | $4,568,241 |
| Kyle W. Gano, Ph.D. | 2019 | $443,400 | $266,040 | $3,000,285 | $1,000,076 | $16,171 | $4,725,972 |
| Kyle W. Gano, Ph.D. | 2020 | $487,700 | $207,273 | $3,749,799 | $2,750,210 | $16,751 | $7,211,733 |
| Eiry W. Roberts, M.D. | 2018 | $490,700 | $220,800 | $2,863,700 | $4,053,869 | $671,554 | $8,300,623 |
| Eiry W. Roberts, M.D. | 2019 | $538,200 | $309,465 | $3,000,285 | $1,000,076 | $51,889 | $4,899,915 |
| Eiry W. Roberts, M.D. | 2020 | $575,900 | $215,963 | $2,624,855 | $2,375,242 | $56,073 | $5,848,033 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm
What are Neurocrine Biosciences Inc's Past Insider Trades?
Neurocrine Biosciences Inc's most recent insider trade came on February 8, 2023 by Julie Cooke who sold 17,079 units worth $1.76M . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $400.2M and bought an estimated value of $67.75M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer, Gary Lyons, Director, and Haig Bozigian, Chief Development Officer .
NEUROCRINE BIOSCIENCES INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||